Combined intra-arterial low-dose 5-fluorouracil, cisplatin, and leucovorin chemotherapy for advanced hepatocellular carcinoma

Journal of the Medical Society of Toho University

Volumn 54, Issue 1, 2007, Pages 21-28

  Nagai, Hidenari ^a   Matsui, Teppei ^a   Kanayama, Masahiro ^a   Momiyama, Kouichi ^a   Ikoma, Akiko ^a   Okano, Naoki ^a   Ikehara, Takashi ^a   Matsumaru, Katsuhiko ^a   Watanabe, Manabu ^a   Iida, Kazunari ^a   Ishii, Koji ^a   Sumino, Yasukiyo ^a   Miki, Kazumasa ^a  

^a TOHO UNIVERSITY   (Japan)

Author keywords

5 FU; Advanced HCC; CDDP; Intra arterial chemotherapy; Liver cirrhosis

Indexed keywords

EID: 34250645875     PISSN: 00408670     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Okuda K, Ohtsuki T, Obata H, et al. : Natural history of hepatocellular carcinoma and prognosis in relation to treatment. Study of 850 patients. Cancer 56 : 918-928, 1985
2. Toyoda H, Nakano S, Kumada T, et al. : The efficacy of continuous local arterial infusion of 5-fluorouracil and cisplatin through an implanted reservoir for severe advanced hepatocellular carcinoma. Oncology 52 : 295-299, 1995
3. Chung YH, Song IH, Song BC, et al.: Combined therapy consisting of intraarterial cisplatin infusion and systemic interferon-α for hepatocellular carcinoma patients with major portal vein thrombosis or distant metastasis. Cancer 88 : 1986-1991, 2000
4. The Cancer of the Liver Italian Program (CLIP) investigators : A new prognostic system for hepatocellular carcinoma : A retrospective study of 435 patients. Hepatology 28 : 751-755, 1998
5. Farinati F, Rinaldi M, Gianni S, et al. : How should patients with hepatocellular carcinoma be staged? Validation of a new prognostic system. Cancer 89 : 2266-2273, 2000
6. Levy I, Sherman M, Liver Cancer Study Group of the University of Toronto : Staging of hepatocellular carcinoma : Assessment of the CLIP, Okuda, and Child-Pugh staging systems in a cohort of 257 patients in Toronto. Gut 50 : 881-885, 2002
7. Ueno S, Tanabe G, Sako K, et al. : Discrimination value of the new Western prognostic system (CLIP score) for hepatocellular carcinoma in 662 Japanese patients. Hepatology 34 : 529-534, 2001
8. Kudo M, Chung H, Osaki Y, et al.: Prognostic staging system for hepatocellular carcinoma (CLIP score) : Its value and limitations, and a proposal for a new staging system, the Japan Integrated Staging Score (JIS score). J Gastroenterol 38 : 207-215, 2003
9. Kudo M, Chung H, Haji S, et al.: Validation of a new prognostic staging system for hepatocellular carcinoma : The JIS score compared with CLIP score. Hepatology 40 : 1396-1405, 2004
10. Yamasaki T, Kurokawa F, Shirahashi H, et al.: Novel arterial infusion chemotherapy using cisplatin, 5-fluorouracil, and leucovorin for patients with advanced hepatocellular carcinoma. Hepatol Res 23 : 7-17, 2002
11. Iwamiya T, Sawada S, Ohta Y: Repeated arterial infusion chemotherapy for inoperable hepatocellular carcinoma using an implantable drug delivery system. Cancer Chemother Pharmacol 33 (suppl) : S134-138, 1994
12. Nagasue N, Yukaya H, Hamada T, et al.: The natural history of hepatocellular carcinoma. A study of 100 untreated cases. Cancer 54 : 1461-1465, 1984
13. Scanlon KJ, Newman EW, Lu Y, et al.: Biochemical basis for cisplatin and 5-fluorouracil synergism in human ovarian carcinoma cells. Proc Natl Acad Sci USA 83 : 8923-8925, 1986
14. Shirasaka T, Shimamoto Y, Ohshimo H, et al.: Metabolic basis of the synergistic antitumor activities of 5-fluorouracil and cisplatin in rodent tumor models in vivo. Cancer Chemother Pharmacol 32 : 167-172, 1993
15. Ensminger WD, Gyves JW : Clinical pharmacology of hepatic arterial chemotherapy. Semin Oncol 10 : 176-182, 1983
16. Okabe H, Satoh S, Kato T, et al.: Genome-wide analysis of gene expression in human hepatocellular carcinomas using cDNA microarray : Identification of genes involved in viral carcinogenesis and tumor progression. Cancer Res 61 : 2129-2137, 2001
17. Iizuka N, Oka M, Yamada-Okabe H, et al. : Comparisonof gene expression profiles between hepatitis B virus- and hepatitis C virus-infected hepatocellular carcinoma by oligonucleotide microarray data on the basis of a supervised learning method. Cancer Res 62 : 3939-3944, 2002
18. Kim W, Oe Lim S, Kim JS, et al. : Comparison of proteome between hepatitis B virus- and hepatitis C virus-associated hepatocellular carcinoma. Clin Cancer Res 9 : 5493-5500, 2003
19. Hanazaki K, Kajikawa S, Koide N, et al.: Prognostic factors after hepatic resection for hepatocellular carcinoma with hepatitis C viral infection : Univariate and multivariate analysis. Am J Gastroenterology 96 : 1243-1250, 2001
20. Aoyagi Y, Isokawa O, Suda T, et al. : The fucosylation index of α-fetoprotein as a possible prognostic indicator for patients with hepatocellular carcinoma. Cancer 83 : 2076-2082, 1998
21. Aoyagi Y, Mita Y, Suda T, et al.: The fucosylation index of serum α-fetoprotein as a useful prognostic factor in patients with hepatocellular carcinoma in special reference to chronological changes. Hepatol Res 23 : 287-295, 2002